Avstera Therapeutics

Philadelphia, United States

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

$5.0M raised

Oct 2023

Seed

Biotechnology Health Care Medical Oncology Therapeutics

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Avstera Therapeutics

How much funding has Avstera Therapeutics raised?

Avstera Therapeutics has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in October 2023.

Where is Avstera Therapeutics headquartered?

Avstera Therapeutics is headquartered in Philadelphia, United States.

What does Avstera Therapeutics do?

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

What stage is Avstera Therapeutics at?

Avstera Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 2, 2023.

MLA

"Avstera Therapeutics — Funding & Investors." VCBacked, October 2, 2023, https://www.vcbacked.co/company/avstera-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2023). Avstera Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/avstera-therapeutics

Wikipedia (cite web)

{{cite web |title=Avstera Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/avstera-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 2, 2023.